GMED (NYSE: GMED) insider files Rule 144 to sell 4,000 shares at $355K

Rhea-AI Filing Summary

GMED has a notice of proposed insider share sales under Rule 144. The filer plans to sell 4,000 shares of GMED common stock through Raymond James & Associates on the NYSE, with an aggregate market value of $355,000. The filing lists 133,839,166 shares of this class outstanding.

The seller acquired 10,000 common shares on 09/01/2023 through restricted stock unit (RSU) vesting from the issuer, and the planned sale represents part of that amount. By signing the notice, the seller represents that they are not aware of any undisclosed material adverse information about GMED’s current or future operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	4000	355000.00	133839166	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2023	RSU Vesting	Issuer			10000	09/01/2023	RSU Vesting

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the GMED Form 144 filing disclose?

It discloses that an affiliate of GMED intends to sell 4,000 shares of GMED common stock on the NYSE under Rule 144, with an aggregate market value of $355,000.

How many GMED shares are planned to be sold and on which exchange?

The notice covers a proposed sale of 4,000 shares of GMED common stock, to be sold on the NYSE through Raymond James & Associates.

How were the GMED shares in this Form 144 acquired?

The filing states that 10,000 GMED common shares were acquired on 09/01/2023 via RSU vesting from the issuer, and the 4,000 shares are part of this amount.

What is the market value of the GMED shares in the planned Rule 144 sale?

The aggregate market value of the 4,000 GMED shares covered by the notice is listed as $355,000.

How many GMED common shares are outstanding according to this notice?

The Form 144 lists 133,839,166 GMED common shares outstanding for the class of securities to be sold.

What representation does the GMED insider make by signing the Form 144?

By signing, the person for whose account the GMED securities are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.